Prophylactic treatment with monoclonal antibodies targeting the CGRP pathway for migraine prevention

Oteri V.; Douba Z.; Rayi A.; Letteri F.; Moscote-Salazar L.R.; Pacheco-Barrios K.; Celani M.G.; Eusebi P.; Ricci S.; Sacco S.; Cantisani T.A. · Cochrane Database of Systematic Reviews (2023) · DOI: 10.1002/14651858.cd015505

Resumen

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of monoclonal antibodies targeting the CGRP pathway compared with placebo or active treatments in preventing or reducing the symptoms of migraine attacks in adult and paediatric patients. Copyright

Instituciones: Universidad San Ignacio de Loyola